School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Divi's Laboratories Limited DIVISLAB.NS

Healthcare · Drug Manufacturers - Specialty & Generic

₹9,340last close 2026-10-09 · delayed data

Trailing returns

1M-1.56%
3M+37.66%
6M+57.56%
1Y+52.94%
5Y+89.87%

Basis: Adjusted daily closes.

What it does

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

Open DIVISLAB.NS in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies